Key Takeaways
- Recurrent implantation failure (RIF) is generally described as the failure to achieve pregnancy after transferring multiple good-quality embryos across several IVF or ICSI cycles, and it affects an estimated 10% of couples undergoing IVF.
- Failed embryo transfer causes are multifactorial and can include chromosomal abnormalities in the embryo, uterine receptivity issues, immunological factors, and sperm quality.
- Chromosomal abnormalities are among the most common IVF failure reasons, yet they often go undetected with standard embryo grading methods.
- Next-generation sequencing (NGS) is a form of advanced genetic testing that screens all 24 chromosome types with 99.98% specificity, identifying abnormalities that older methods can miss.
- Selecting chromosomally normal (euploid) embryos for transfer through NGS-based testing can reduce failed cycles, lower miscarriage risk, and improve pregnancy outcomes.
- Recurrent implantation failure treatment starts with a thorough investigation of all possible contributing factors, and Bangkok Central Clinic offers personalized assessment and NGS testing for couples facing repeated IVF setbacks.
Recurrent implantation failure happens when good-quality embryos are transferred across multiple IVF cycles and pregnancy still does not occur. It affects roughly 10% of IVF couples, and one of the most common yet overlooked IVF failure reasons is chromosomal abnormalities within the embryo itself. These genetic issues are invisible to standard embryo grading but can now be detected through advanced genetic testing using NGS in Bangkok. For couples facing repeated failed embryo transfer causes that remain unexplained, understanding the genetic side of implantation failure is often the missing piece.
What Is Recurrent Implantation Failure?
Recurrent implantation failure is generally described as the inability to achieve a clinical pregnancy after transferring good-quality embryos across multiple IVF or ICSI cycles. While there is no single universally accepted definition, most fertility specialists consider RIF after three or more failed transfer attempts with quality embryos.
According to research published through the National Institutes of Health, RIF affects approximately 10% of couples undergoing IVF treatment. Some studies suggest the number may be as high as 25% depending on how the condition is defined and the patient population studied.
It is important to understand that RIF is a diagnosis that calls for deeper investigation, not a dead end. For many couples, the emotional toll of repeated failures brings frustration, confusion, and self-doubt. Those feelings are valid, but they do not mean the journey is over. RIF signals that something specific is interfering with implantation, and identifying that factor is the key to moving forward with an effective recurrent implantation failure treatment plan.
What Causes Recurrent Implantation Failure?
The failed embryo transfer causes behind RIF are rarely simple. Implantation depends on a complex interaction between the embryo and the uterine environment, and problems can arise from multiple directions at once. The main categories include:
- Embryo-related factors such as chromosomal abnormalities (aneuploidy), which are among the most frequent causes of implantation failure and early pregnancy loss
- Uterine factors including structural abnormalities like polyps, fibroids, or uterine septum, as well as issues with endometrial receptivity and lining thickness
- Immunological factors where the body’s immune response may interfere with embryo attachment or early development
- Sperm quality factors including high DNA fragmentation, which can affect embryo development even after successful fertilization
- Unexplained causes where standard testing does not reveal a clear reason for repeated failure
Among these, chromosomal abnormalities in the embryo stand out as one of the most significant yet frequently overlooked IVF failure reasons. Research shows that nearly 70% of arrested embryos carry chromosomal errors, and studies on blastocyst-stage embryos have found that roughly 45 to 60% may be aneuploid, depending on maternal age.
The challenge is that many of these aneuploid embryos look perfectly normal under standard morphological assessment. Without genetic screening, they can be selected for transfer and result in another failed cycle.
The Genetic Reason That Often Goes Undetected
When embryos are graded in the laboratory, embryologists assess visible features like cell division patterns, symmetry, and overall appearance. An embryo can receive a high quality score and still carry chromosomal abnormalities that make successful implantation unlikely.
This is one of the most frustrating aspects of RIF for couples and clinicians alike. The embryos looked good. The transfer went smoothly. The uterine lining was prepared properly. Yet the result was negative. In many of these cases, the embryo itself carried a genetic issue that was invisible to conventional assessment.
Chromosomal abnormalities, particularly aneuploidy (having too many or too few chromosomes), are a leading cause of both recurrent implantation failure and early pregnancy loss. The risk increases with maternal age, but aneuploid embryos can occur at any age. Older screening methods like FISH (Fluorescence In Situ Hybridization) could only analyze a limited number of chromosomes, leaving many abnormalities undetected.
This is where newer technology changes the picture. Rather than viewing this as a criticism of previous treatment, it represents an opportunity. More precise screening methods now exist that can identify these hidden issues and guide better embryo selection for transfer.
What Is NGS and How Does It Help?
NGS stands for next-generation sequencing. It is an advanced form of preimplantation genetic testing (PGT-A) that screens embryos across all 24 types of chromosomes with a level of detail that older methods simply could not achieve.
According to a validation study published through the National Institutes of Health, NGS demonstrated 100% sensitivity (no false negatives) and 99.98% specificity (near-zero false positives) for aneuploidy detection. This means the technology is remarkably accurate at identifying which embryos carry chromosomal abnormalities and which are euploid (chromosomally normal).
Unlike older techniques that could analyze only a limited number of chromosomes, NGS provides comprehensive screening that can detect whole chromosome gains and losses as well as subtler segmental deletions and duplications. This depth of analysis is especially valuable for couples experiencing recurrent implantation failure, because it reveals problems that would otherwise remain hidden.
The practical benefit is clear: by selecting only euploid embryos for transfer, couples can reduce the number of failed cycles, lower the risk of miscarriage, and improve their overall chances of a healthy pregnancy. NGS-based advanced genetic testing is particularly recommended for patients with multiple failed IVF cycles, recurrent miscarriages, advanced maternal age, or known genetic risk factors.
How NGS Testing Works at Bangkok Central Clinic
The NGS testing process at Bangkok Central Clinic is designed to be thorough without being overwhelming. Here is how it works:
Step 1: Embryo development to blastocyst stage After fertilization through IVF or ICSI, embryos are cultured in the laboratory for five to six days until they reach the blastocyst stage.
Step 2: Trophectoderm biopsy A small number of cells are carefully collected from the trophectoderm (the outer layer of the blastocyst that will become the placenta). This biopsy is performed by experienced embryologists and does not compromise embryo viability.
Step 3: DNA amplification and chromosomal sequencing The collected cells undergo DNA amplification, followed by comprehensive chromosomal analysis using NGS technology.
Step 4: Results and embryo selection Results are typically available within a few days. The fertility team reviews the findings with the couple, identifying which embryos are euploid and most suitable for transfer.
Step 5: Frozen embryo transfer Selected healthy embryos are transferred during a subsequent cycle. Remaining euploid embryos can be cryopreserved for future use.
The NGS IVF testing package in Bangkok at Bangkok Central Clinic includes embryo biopsy, laboratory sequencing and analysis, genetic counseling and results interpretation, and support in selecting the best embryos for transfer.
Why Consider Bangkok Central Clinic for RIF Assessment and Treatment
Recurrent implantation failure treatment requires a clinic that can investigate all the contributing factors, not just one. Bangkok Central Clinic takes a comprehensive approach, combining thorough diagnostic assessment with access to advanced reproductive technology.
The clinic offers inclusive fertility services for couples, individuals, and LGBTQ+ families, with care plans designed for both local and international patients. The team includes experienced fertility specialists and embryologists who work with state-of-the-art laboratory equipment, including NGS-capable genetic testing platforms.
What sets Bangkok Central Clinic apart in complex cases like RIF is the boutique, doctor-led approach. Patients work with the same specialist throughout their journey, ensuring continuity and a complete understanding of their clinical history. Treatment plans are personalized because no two RIF cases are the same, and a one-size-fits-all protocol rarely delivers results for couples who have already been through multiple failed cycles.
Transparent pricing and comprehensive treatment packages make it easier for patients to plan, and multilingual support ensures international patients receive clear communication at every step.
Taking the Next Step
If you have been through multiple IVF cycles without success, seeking answers is a sign of strength, not failure. Understanding the failed embryo transfer causes behind your experience is the first step toward a different outcome.
Book a consultation at Bangkok Central Clinic to discuss your history and explore whether NGS-based genetic testing is appropriate for your situation. Every case is unique, and a personalized assessment can help determine the most effective path forward.
Disclaimer: Treatment outcomes vary between individuals. Bangkok Central Clinic does not guarantee specific results. All treatment recommendations are based on individual medical assessment in accordance with Thai medical advertising regulations.
References:
Recurrent implantation failure: A comprehensive summary from etiology to treatment. Retrieved on 30 April, 2026 from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9849692/
Frequently Asked Questions About Recurrent Implantation Failure
Q: What is recurrent implantation failure?
A: Recurrent implantation failure (RIF) is a condition where pregnancy does not occur despite transferring good-quality embryos across multiple IVF or ICSI cycles. While there is no single universal definition, most specialists consider RIF after three or more failed transfers. It affects an estimated 10% of IVF patients and requires further investigation to identify the underlying cause.
Q: What are the most common failed embryo transfer causes?
A: The most common failed embryo transfer causes include chromosomal abnormalities in the embryo, issues with uterine receptivity or structure, immunological factors, and sperm DNA fragmentation. In many cases, chromosomal abnormalities are the primary factor but remain undetected without genetic screening.
Q: Can an embryo that looks healthy still fail to implant?
A: Yes. Standard embryo grading assesses visible features like cell structure and development speed. However, an embryo can appear morphologically normal while carrying chromosomal abnormalities that prevent successful implantation. This is why genetic screening through NGS can provide critical information that visual assessment cannot.
Q: What is NGS and how accurate is it?
A: NGS (next-generation sequencing) is a form of preimplantation genetic testing that screens all 24 chromosome types in an embryo. Published research shows NGS achieves 100% sensitivity and 99.98% specificity for detecting aneuploidy, making it one of the most precise screening tools available in reproductive medicine.
Q: Is NGS testing safe for the embryo?
A: Yes. The biopsy involves collecting a small number of cells from the trophectoderm (outer layer) of the blastocyst. This layer develops into the placenta, not the baby. When performed by experienced embryologists, the procedure does not compromise embryo viability.
